Drugs Targeting Cancer Stem Cells
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
27
NCT06487221
Avutometinib and Defactinib in Diffuse Gastric Cancer
Phase: Phase 2
Role: Collaborator
Start: Oct 28, 2024
Completion: May 30, 2029
Loading map...